Job opportunity with the IAEA

Great opportunity to work at the IAEA! A 2-year global health position is for a Junior professional (JPO) in the Division of Human Health (NAHU) supported through the US government.   Click here for job listing. Apply through Argonne National labs.

April 30th deadline!


“I think the message is very simple: it’s wasteful not to invest in health”

The alarming report released by the WHO details the staggering drain that disease has on the African economy. It projects that by 2030, the loss in GDP could be almost $1.7 trillion unless ambitious goals to increase the investment in health care improvement are met. The report also highlights the large percentage (37%) that non-communicable diseases account for in this burden. The necessary shift to translate political commitments into investment is possible by implementing changes not only to treat disease but to promote good health and prevention.
Read more…

Changing the Global Radiation Therapy Paradigm

Read the recent journal article  “Changing the global radiation therapy paradigm”, written by ICEC Chief Scientific Program Director, David A. Pistenmaa and others, published in Radiotherapy and Oncology.   Filling the gap in cancer care in underserved regions worldwide requires global collaboration and concerted effort to share creative ideas, pool talents and develop sustainable support from governments, industry, academia and non-governmental organizations. Comprehensive cancer care, which fits within and strengthens the broader healthcare system, ranges from prevention to screening, to curative treatment, to palliative care and to long-term follow-up. Radiation therapy is an essential component for curative and palliative cancer care and can serve as a stable focal point physically and for personnel around which regional cancer and health care programs can be established. Read the article…

Radiotherapy and Oncology logo

Bridging the Gap: working to bring state-of-the-art radiation therapy to challenging environments

The International Cancer Expert Corps, in a cooperative effort with CERN and the UK Science and Technology Facilities Council STFC, is undertaking an initiative to develop innovative, robust and affordable medical linear accelerators for use in low- to middle-income countries.  The article, “Bridging the Gap”, January 15, 2018, CERN COURIER, outlines the history of this project including the recent participation of representatives from Official Development Assistance (ODA) countries in an effort to ensure their particular needs regarding power systems, safety, operability and maintenance are addressed. Read the article…

Participating individuals from ICEC, CERN and STFC, along with experts in accelerator design, medical physics and oncology,  convened in late March, in Manchester, England near the STFC’s Daresbury Laboratory to review the program status and plan for the next phase of development. Watch this space for updates.


A Check Up on U.S. Global Health Policy, After One Year of the Trump Administration

Kaiser Family Foundation takes stock of the U.S. global health response after the first year of the Trump Presidency and looks ahead to the global health policy issues that are likely to have our attention. One interesting fact garnered from a recent KFF poll, is that about a half of the public still wants the U.S to play a major or leading roll in improving health in developing countries. Issue-Brief-A-Check-Up-on-US-Global-Health-Policy-After-One-Year-of-the-Trump-Administration

World Politics Review published ICEC authored article, “How Better Cancer Treatment Can Also Mean Better Nuclear Security”

Today,  World Politics Review, published the article, “How Better Cancer Treatment Can Also Mean Better Nuclear Security” authored by Dr. C. Norm Coleman, Miles Pomper and Dr. Silvia Formenti. The article was written in response to the Washington Post article, “How ISIS nearly stumbled on the ingredients for a ‘dirty bomb’” which discussed the dilemma related to the risk of terrorists developing dirty bombs from materials used for cancer treatment in developing countries.  These countries need better technology and treatment environments, not only to support a transition away from cobalt-60 machines but to improve cancer treatment overall.

Read More